Search
for
Sort by
Research 61–90 of 1000+
- Common Variants in the Sex Hormone-Binding Globulin (SHBG) Gene Influence SHBG Levels in Women with Polycystic Ovary Syndrome
- Ferulic Acid Inhibits Catamenial Epilepsy Through Modulation of Female Hormones
- Thyrotropin-releasing hormone and oestrogen differentially regulate prolactin and prolactin receptor expression in female human skin and hair follicles <i>in vitro</i>
- Luteinizing Hormone and Human Chorionic Gonadotropin Decrease Type 2 5α-Reductase and Androgen Receptor Protein Levels in Women’s Skin
- Associations of prenatal and postnatal exposure to perfluoroalkyl substances with pubertal development and reproductive hormones in females and males: The HOME study
- Investigation Of Serum Level Of T4, TSH, Free Testosterone And Prolactin Hormones As Well As Alb And SHBG Proteins In Women With Hair Loss Vs. Those Without Hair Loss
- A Single Injection of the Anabolic Bone Agent, Parathyroid Hormone–Collagen Binding Domain (PTH–CBD), Results in Sustained Increases in Bone Mineral Density for up to 12 Months in Normal Female Mice
- Effect of the gonadotrophin releasing hormone analogue, goserelin, and oestradiol replacement on sebum excretion rates and hair size in mildly hirsute women
- Efficacy of topical minoxidil in enhancing beard growth in a group of transgender assigned female at birth individuals on gender affirming hormone therapy
- Effects of <i>KISS1</i> structural polymorphism on the risk of polycystic ovary syndrome and reproductive hormones in Iraqi women who take metformin
- [Current treatment of androgenetic male and female alopecia (with the exception of hormone treatment)].
- Effect of Leuprolide and Dexamethasone on Hair Growth and Hormone Levels in Hirsute Women: The Relative Importance of the Ovary and the Adrenal in the Pathogenesis of Hirsutism*
- The Effect of Simvastatin on Plasma Steroid Hormone Levels in Metformin-Treated Women with Non-Classic Congenital Adrenal Hyperplasia
- Medications affecting the insulin-like growth factor 1/growth hormone axis, including teprotumumab, somatostatin analogs, and anti-calcitonin gene-related peptide monoclonal antibodies, are associated with elevated reporting odds of alopecia in women: A pharmacovigilance study
- Ferulic acid inhibits catamenial epilepsy through modulation of female hormones
- The Effect of Leonuri Herba alkaloids on Senile BPH (male and female hormone induced) model rats
- Differential Suppression of Testosterone and Estradiol in Hirsute Women With the Superactive Gonadotropin-Releasing Hormone Agonist Leuprolide*
- Chemical Structure, Classification and Clinical Significance of Steroid Hormones: A Review Article
- Assessment of Female Sexual Dysfunction in Patients with Premenopausal Female Pattern Hair Loss
- Ovarian hormones and adrenal androgens during a woman's life span
- Approach to the adult female patient with diffuse nonscarring alopecia
- Female Androgenic Alopecia
- Female pattern hair loss: Clinical features and potential hormonal factors
- HSD3B1 gene polymorphism and female pattern hair loss in women with polycystic ovary syndrome
- Obesity and female androgenic alopecia: A cause and an effect?
- Female hair concerns with age
- Alterations in androgen conjugate levels in women and men with alopecia
- A REVIEW ON PREVALENCE, CAUSES, AND TREATMENT STRATEGIES OF HAIR FALL AMONG MEN AND WOMEN
- A REVIEW ON PREVALENCE, CAUSES, AND TREATMENT STRATEGIES OF HAIR FALL AMONG MEN AND WOMEN
- EXPRESS: Free androgen index and its relation with female pattern hair loss